Friday, April 17, 2009


EuroCor gets CE mark for TAXCOR

BANGALORE: EuroCor Life Sciences, a wholly owned subsidiary of healthcare equipment maker Opto Circuits (India) Ltd (OCIL), has received CE approval for marketing and sale of drug eluting stents called TAXCOR. "Obtaining this approval allows EuroCor to sell TAXCOR globally, with the exception of the U.S. and Japan. TAXCOR has a current addressable market of at least 40 per cent of the large global market," says Vinod Ramnani, Chairman and Managing Director, OCIL.

Printer friendly page   
Send this article to Friends by E-Mail





SOURCE

No comments:

Post a Comment